Different Units By MoH Code
Revision Date : 11/01/2013
NovoSeven RT 250KIU MoH 5541 :
Form
Powder and solvent for solution for injection
Packaging
Pre-filled Syringes + Vials (Type I glass)
Package Size
1+1
Strength
5mg (250KIU)
Public Price
4222855 L.L.
Stratum
E2
NSSF
✔
Quarantine
✘
Reg. Number
218017/09
Submission date
01/01/2009
Registration Year
2009
abcdefhiklmnopqrstuvwxyz Loading chart. Please wait. abcdefhiklmnopqrstuvwxyz Date Price 0 80M 160M 240M 320M 400M 2009-09-30 2009-10-24 2010-03-27 2010-04-20 2010-05-15 2010-05-31 2010-07-31 2010-10-14 2010-10-29 2010-12-01 2011-01-04 2011-06-14 2011-10-22 2012-04-05 2012-07-27 2012-12-21 2013-01-07 2013-04-02 2013-10-11 2014-03-26 2014-06-19 2014-10-14 2015-01-13 2015-04-07 2015-07-30 2015-11-30 2016-01-11 2016-04-11 2016-12-09 2017-01-11 2017-06-16 2017-11-09 2018-01-22 2018-02-19 2018-05-17 2018-08-20 2018-12-21 2019-02-01 2019-08-28 2019-12-17 2020-01-09 2020-03-02 2020-07-02 2020-08-03 2020-12-03 2021-09-03 2021-11-03 2021-12-07 2022-03-01 2022-05-11 2022-07-14 2022-10-04 2022-11-01 2022-12-12 2023-04-03 2023-09-05 2023-12-05 2024-01-10 2024-02-05 2024-06-13
●
Country:
Italy
●
Package Size:
1+1x5.2ml
●
Public Price:
5395.61 EUR
( 522,705,114.36 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
5395,61 EUR
( 522,646,020.00 LBP )
●
Exfactory Price:
3269.25 EUR
●
Pricing Date:
17/12/2019
●
Type:
Medicine Authorised
●
Country:
Qatar
●
Package Size:
1 powder vial + 1 Solvent pre-filled syringe + vial adapter
●
Public Price:
19816 QAR
( 486,641,328.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
19816 QAR
( 486,641,328.00 LBP )
●
Pharmacy Price:
16277.33865628 QAR
( 399738882.72092 LBP )
●
Pricing Date:
28/01/2021
●
Type:
Medicine Authorised
●
Country:
Oman
●
Package Size:
1+1
●
Public Price:
2086.42 OMR
( 481,408,032.28 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
2086,42 OMR
( 481,311,124.00 LBP )
●
Pricing Date:
19/02/2021
●
Type:
Medicine Authorised
●
Country:
Kuweit
●
Package Size:
1+1
●
Public Price:
1596.98 KWD
( 468,842,985.38 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
1596,98 KWD
( 468,555,276.00 LBP )
●
Pharmacy Price:
1349.17 KWD
( 396090677.77 LBP )
●
Pricing Date:
07/02/2021
●
Type:
Medicine Authorised
●
Country:
Switzerland
●
Package Size:
1+1
●
Public Price:
4370.8 CHF
( 452,028,136.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
4370,8 CHF
( 451,945,400.00 LBP )
●
Exfactory Price:
4224.2 CHF
●
Pricing Date:
04/04/2021
●
Type:
Medicine Authorised
●
Country:
Abu Dhabi
●
Package Size:
1+1
●
Public Price:
18517 AED
( 447,389,237.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
18517 AED
( 447,389,237.00 LBP )
●
Pharmacy Price:
15773.8 AED
( 381110781.8 LBP )
●
Pricing Date:
27/01/2021
●
Type:
Medicine Authorised
●
Country:
UAE
●
Package Size:
1 Vial (Powder) + 1 Solvent Vial (2.1ml)
●
Public Price:
18517 AED
( 447,389,237.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
18517 AED
( 447,389,237.00 LBP )
●
Pharmacy Price:
15773.78 AED
( 381110298.58 LBP )
●
Pricing Date:
21/08/2019
●
Type:
Medicine Authorised
●
Country:
Bahrain
●
Package Size:
1+1
●
Public Price:
1761.26 BHD
( 418,711,384.84 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
1761,26 BHD
( 418,649,574.00 LBP )
●
Reference:
nhra
●
Pricing Date:
09/02/2021
●
Type:
Medicine Authorised
●
Country:
Finland
●
Package Size:
1+1
●
Public Price:
3888.15 EUR
( 376,668,419.40 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
3888,15 EUR
( 376,653,888.00 LBP )
●
Reference:
Kela
●
Pricing Date:
22/04/2021
●
Type:
Medicine Authorised
●
Country:
Denmark
●
Package Size:
1+1
●
Public Price:
26563.3 DKK
( 344,685,380.80 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
26563,3 DKK
( 344,681,488.00 LBP )
●
Pharmacy Price:
19744.6 DKK
( 256205929.6 LBP )
●
Reference:
Danish Medicine Agency
●
Pricing Date:
19/05/2021
●
Type:
Medicine Authorised
●
Country:
Iceland
●
Package Size:
1+1
●
Public Price:
532896 ISK
( 343,717,920.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
532896 ISK
( 343,717,920.00 LBP )
●
Pharmacy Price:
423362 ISK
( 273068490 LBP )
●
Reference:
Icelandic Medicines Agency
●
Pricing Date:
01/04/2020
●
Type:
Medicine Authorised
●
Country:
Czech Republic
●
Package Size:
1+1x5.2ml
●
Public Price:
85264.46 CZK
( 325,624,972.74 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
85264,46 CZK
( 325,623,216.00 LBP )
●
Reference:
SUKL
●
Pricing Date:
28/02/2020
●
Type:
Medicine Authorised
●
Country:
KSA
●
Package Size:
3mg
●
Public Price:
13202.15 SAR
( 312,098,826.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
13202,15 SAR
( 312,095,280.00 LBP )
●
Reference:
sfda
●
Pricing Date:
16/01/2021
●
Type:
Medicine Authorised
●
Country:
UK
●
Package Size:
1+1
●
Public Price:
2626 GBP
( 298,442,274.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
2626 GBP
( 298,442,274.00 LBP )
●
Reference:
DMD
●
Pricing Date:
08/03/2021
●
Type:
Medicine Authorised
●
Country:
Spain
●
Package Size:
1 vial + 1xdisolvente
●
Public Price:
3062.98 EUR
( 296,729,250.48 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
3062,98 EUR
( 296,634,312.00 LBP )
●
Reference:
Agencia Española de Medicamentos y Productos Sanitarios
●
Pricing Date:
06/05/2021
●
Type:
Medicine Non Marketed
●
Country:
France
●
Package Size:
1+1
●
Public Price:
3040 EUR
( 294,503,040.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
3040 EUR
( 294,503,040.00 LBP )
●
Reference:
ansm
●
Pricing Date:
15/05/2021
●
Type:
Medicine Authorised
●
Country:
Belgium
●
Package Size:
1+1x5.2ml
●
Public Price:
2662 EUR
( 257,883,912.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
2662 EUR
( 257,883,912.00 LBP )
●
Medica Comments:
Withdrawn on november 2018
●
Reference:
cbip
●
Pricing Date:
02/12/2020
●
Type:
Medicine Authorised
●
Country:
Norway
●
Package Size:
1
●
Public Price:
30097 NOK
( 243,906,088.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
30097 NOK
( 243,906,088.00 LBP )
●
Pharmacy Price:
23577.07 NOK
( 191068575.28 LBP )
●
Reference:
Norwegian Medicine Agency
●
Pricing Date:
01/04/2020
●
Type:
Medicine Authorised
●
Country:
Sweden
●
Package Size:
1+1
●
Public Price:
28482.76 SEK
( 239,483,046.08 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
28482,76 SEK
( 239,476,656.00 LBP )
●
Pharmacy Price:
27878.93 SEK
( 234406043.44 LBP )
●
Pricing Date:
23/04/2020
●
Type:
Medicine Authorised
●
Country:
Turkey
●
Package Size:
1
●
Public Price:
12895.82 TRY
( 34,560,797.60 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
12895,82 TRY
( 34,558,600.00 LBP )
●
Pricing Date:
28/10/2020
●
Type:
Medicine Authorised
●
Country:
Lebanon
●
Form:
Powder and solvent for solution for injection
●
Package Size:
1+1
●
Public Price:
4222855 LBP
( 4,222,855.00 LBP )
●
Pack size unit used:
1
●
Cost/Unit:
4222855 LBP
( 4,222,855.00 LBP )
●
Pricing Date:
13/06/2024
●
Country:
Portugal
●
Package Size:
1+1
●
Reference:
Autoridade Nacional do Medicamento e Produtos de Saúde
●
Pricing Date:
22/04/2019
●
Country:
Greece
●
Package Size:
1+1
●
Reference:
National Organization for Medicines
●
Pricing Date:
25/03/2019
●
Type:
Medicine Non Marketed
●
Country:
New Zealand
●
Package Size:
1 inj
●
Exfactory Price:
5891.5 NZD
●
Reference:
New Zealand Pharmaceutical Management Agency
●
Pricing Date:
01/04/2020
●
Type:
Medicine Authorised
●
Country:
The Netherlands
●
Package Size:
1
●
Reference:
Zorginstituut Nederland
●
Pricing Date:
15/06/2019
●
Type:
Medicine Non Marketed
abcdefhiklmnopqrstuvwxyz Loading chart. Please wait. abcdefhiklmnopqrstuvwxyz Country Price/Unit 0 120M 240M 360M 480M 600M Italy Qatar Oman Kuweit Switzerland Abu Dhabi UAE Bahrain Finland Denmark Iceland Czech Republic KSA UK Spain France Belgium Norway Sweden Turkey Lebanon
Acquired haemophilia :
●
Cost/Unit:
5395,61 EUR
( 522,646,020.00 LBP )
● Cost/Day:
10791,22 EUR
( 1,045,388,916.00 LBP )
●
Cost/Month:
10791,22 EUR
( 1,045,388,916.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
5395,61 EUR
( 522,646,020.00 LBP )
● Cost/Day:
10791,22 EUR
( 1,045,388,916.00 LBP )
●
Cost/Month:
10791,22 EUR
( 1,045,388,916.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
5395,61 EUR
( 522,646,020.00 LBP )
● Cost/Day:
10791,22 EUR
( 1,045,388,916.00 LBP )
●
Cost/Month:
10791,22 EUR
( 1,045,388,916.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
5395,61 EUR
( 522,646,020.00 LBP )
● Cost/Day:
10791,22 EUR
( 1,045,388,916.00 LBP )
●
Cost/Month:
10791,22 EUR
( 1,045,388,916.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
5395,61 EUR
( 522,646,020.00 LBP )
● Cost/Day:
10791,22 EUR
( 1,045,388,916.00 LBP )
●
Cost/Month:
10791,22 EUR
( 1,045,388,916.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
19816 QAR
( 486,641,328.00 LBP )
● Cost/Day:
39632 QAR
( 973,282,656.00 LBP )
●
Cost/Month:
39632 QAR
( 973,282,656.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
19816 QAR
( 486,641,328.00 LBP )
● Cost/Day:
39632 QAR
( 973,282,656.00 LBP )
●
Cost/Month:
39632 QAR
( 973,282,656.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
19816 QAR
( 486,641,328.00 LBP )
● Cost/Day:
39632 QAR
( 973,282,656.00 LBP )
●
Cost/Month:
39632 QAR
( 973,282,656.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
19816 QAR
( 486,641,328.00 LBP )
● Cost/Day:
39632 QAR
( 973,282,656.00 LBP )
●
Cost/Month:
39632 QAR
( 973,282,656.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
19816 QAR
( 486,641,328.00 LBP )
● Cost/Day:
39632 QAR
( 973,282,656.00 LBP )
●
Cost/Month:
39632 QAR
( 973,282,656.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
2086,42 OMR
( 481,311,124.00 LBP )
● Cost/Day:
4172,84 OMR
( 962,622,248.00 LBP )
●
Cost/Month:
4172,84 OMR
( 962,622,248.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
2086,42 OMR
( 481,311,124.00 LBP )
● Cost/Day:
4172,84 OMR
( 962,622,248.00 LBP )
●
Cost/Month:
4172,84 OMR
( 962,622,248.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
2086,42 OMR
( 481,311,124.00 LBP )
● Cost/Day:
4172,84 OMR
( 962,622,248.00 LBP )
●
Cost/Month:
4172,84 OMR
( 962,622,248.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
2086,42 OMR
( 481,311,124.00 LBP )
● Cost/Day:
4172,84 OMR
( 962,622,248.00 LBP )
●
Cost/Month:
4172,84 OMR
( 962,622,248.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
2086,42 OMR
( 481,311,124.00 LBP )
● Cost/Day:
4172,84 OMR
( 962,622,248.00 LBP )
●
Cost/Month:
4172,84 OMR
( 962,622,248.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
1596,98 KWD
( 468,555,276.00 LBP )
● Cost/Day:
3193,96 KWD
( 937,404,133.00 LBP )
●
Cost/Month:
3193,96 KWD
( 937,404,133.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
1596,98 KWD
( 468,555,276.00 LBP )
● Cost/Day:
3193,96 KWD
( 937,404,133.00 LBP )
●
Cost/Month:
3193,96 KWD
( 937,404,133.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
1596,98 KWD
( 468,555,276.00 LBP )
● Cost/Day:
3193,96 KWD
( 937,404,133.00 LBP )
●
Cost/Month:
3193,96 KWD
( 937,404,133.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
1596,98 KWD
( 468,555,276.00 LBP )
● Cost/Day:
3193,96 KWD
( 937,404,133.00 LBP )
●
Cost/Month:
3193,96 KWD
( 937,404,133.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
1596,98 KWD
( 468,555,276.00 LBP )
● Cost/Day:
3193,96 KWD
( 937,404,133.00 LBP )
●
Cost/Month:
3193,96 KWD
( 937,404,133.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
4370,8 CHF
( 451,945,400.00 LBP )
● Cost/Day:
8741,6 CHF
( 903,994,220.00 LBP )
●
Cost/Month:
8741,6 CHF
( 903,994,220.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
4370,8 CHF
( 451,945,400.00 LBP )
● Cost/Day:
8741,6 CHF
( 903,994,220.00 LBP )
●
Cost/Month:
8741,6 CHF
( 903,994,220.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
4370,8 CHF
( 451,945,400.00 LBP )
● Cost/Day:
8741,6 CHF
( 903,994,220.00 LBP )
●
Cost/Month:
8741,6 CHF
( 903,994,220.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
4370,8 CHF
( 451,945,400.00 LBP )
● Cost/Day:
8741,6 CHF
( 903,994,220.00 LBP )
●
Cost/Month:
8741,6 CHF
( 903,994,220.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
4370,8 CHF
( 451,945,400.00 LBP )
● Cost/Day:
8741,6 CHF
( 903,994,220.00 LBP )
●
Cost/Month:
8741,6 CHF
( 903,994,220.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
18517 AED
( 447,389,237.00 LBP )
● Cost/Day:
37034 AED
( 894,778,474.00 LBP )
●
Cost/Month:
37034 AED
( 894,778,474.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
18517 AED
( 447,389,237.00 LBP )
● Cost/Day:
37034 AED
( 894,778,474.00 LBP )
●
Cost/Month:
37034 AED
( 894,778,474.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
18517 AED
( 447,389,237.00 LBP )
● Cost/Day:
37034 AED
( 894,778,474.00 LBP )
●
Cost/Month:
37034 AED
( 894,778,474.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
18517 AED
( 447,389,237.00 LBP )
● Cost/Day:
37034 AED
( 894,778,474.00 LBP )
●
Cost/Month:
37034 AED
( 894,778,474.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
18517 AED
( 447,389,237.00 LBP )
● Cost/Day:
37034 AED
( 894,778,474.00 LBP )
●
Cost/Month:
37034 AED
( 894,778,474.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
18517 AED
( 447,389,237.00 LBP )
● Cost/Day:
37034 AED
( 894,778,474.00 LBP )
●
Cost/Month:
37034 AED
( 894,778,474.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
18517 AED
( 447,389,237.00 LBP )
● Cost/Day:
37034 AED
( 894,778,474.00 LBP )
●
Cost/Month:
37034 AED
( 894,778,474.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
18517 AED
( 447,389,237.00 LBP )
● Cost/Day:
37034 AED
( 894,778,474.00 LBP )
●
Cost/Month:
37034 AED
( 894,778,474.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
18517 AED
( 447,389,237.00 LBP )
● Cost/Day:
37034 AED
( 894,778,474.00 LBP )
●
Cost/Month:
37034 AED
( 894,778,474.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
18517 AED
( 447,389,237.00 LBP )
● Cost/Day:
37034 AED
( 894,778,474.00 LBP )
●
Cost/Month:
37034 AED
( 894,778,474.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
1761,26 BHD
( 418,649,574.00 LBP )
● Cost/Day:
3522,52 BHD
( 837,299,148.00 LBP )
●
Cost/Month:
3522,52 BHD
( 837,299,148.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
1761,26 BHD
( 418,649,574.00 LBP )
● Cost/Day:
3522,52 BHD
( 837,299,148.00 LBP )
●
Cost/Month:
3522,52 BHD
( 837,299,148.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
1761,26 BHD
( 418,649,574.00 LBP )
● Cost/Day:
3522,52 BHD
( 837,299,148.00 LBP )
●
Cost/Month:
3522,52 BHD
( 837,299,148.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
1761,26 BHD
( 418,649,574.00 LBP )
● Cost/Day:
3522,52 BHD
( 837,299,148.00 LBP )
●
Cost/Month:
3522,52 BHD
( 837,299,148.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
1761,26 BHD
( 418,649,574.00 LBP )
● Cost/Day:
3522,52 BHD
( 837,299,148.00 LBP )
●
Cost/Month:
3522,52 BHD
( 837,299,148.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
3888,15 EUR
( 376,653,888.00 LBP )
● Cost/Day:
7776,3 EUR
( 753,307,776.00 LBP )
●
Cost/Month:
7776,3 EUR
( 753,307,776.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
3888,15 EUR
( 376,653,888.00 LBP )
● Cost/Day:
7776,3 EUR
( 753,307,776.00 LBP )
●
Cost/Month:
7776,3 EUR
( 753,307,776.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
3888,15 EUR
( 376,653,888.00 LBP )
● Cost/Day:
7776,3 EUR
( 753,307,776.00 LBP )
●
Cost/Month:
7776,3 EUR
( 753,307,776.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
3888,15 EUR
( 376,653,888.00 LBP )
● Cost/Day:
7776,3 EUR
( 753,307,776.00 LBP )
●
Cost/Month:
7776,3 EUR
( 753,307,776.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
3888,15 EUR
( 376,653,888.00 LBP )
● Cost/Day:
7776,3 EUR
( 753,307,776.00 LBP )
●
Cost/Month:
7776,3 EUR
( 753,307,776.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
26563,3 DKK
( 344,681,488.00 LBP )
● Cost/Day:
53126,6 DKK
( 689,362,976.00 LBP )
●
Cost/Month:
53126,6 DKK
( 689,362,976.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
26563,3 DKK
( 344,681,488.00 LBP )
● Cost/Day:
53126,6 DKK
( 689,362,976.00 LBP )
●
Cost/Month:
53126,6 DKK
( 689,362,976.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
26563,3 DKK
( 344,681,488.00 LBP )
● Cost/Day:
53126,6 DKK
( 689,362,976.00 LBP )
●
Cost/Month:
53126,6 DKK
( 689,362,976.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
26563,3 DKK
( 344,681,488.00 LBP )
● Cost/Day:
53126,6 DKK
( 689,362,976.00 LBP )
●
Cost/Month:
53126,6 DKK
( 689,362,976.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
26563,3 DKK
( 344,681,488.00 LBP )
● Cost/Day:
53126,6 DKK
( 689,362,976.00 LBP )
●
Cost/Month:
53126,6 DKK
( 689,362,976.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
532896 ISK
( 343,717,920.00 LBP )
● Cost/Day:
1065792 ISK
( 687,435,840.00 LBP )
●
Cost/Month:
1065792 ISK
( 687,435,840.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
532896 ISK
( 343,717,920.00 LBP )
● Cost/Day:
1065792 ISK
( 687,435,840.00 LBP )
●
Cost/Month:
1065792 ISK
( 687,435,840.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
532896 ISK
( 343,717,920.00 LBP )
● Cost/Day:
1065792 ISK
( 687,435,840.00 LBP )
●
Cost/Month:
1065792 ISK
( 687,435,840.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
532896 ISK
( 343,717,920.00 LBP )
● Cost/Day:
1065792 ISK
( 687,435,840.00 LBP )
●
Cost/Month:
1065792 ISK
( 687,435,840.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
532896 ISK
( 343,717,920.00 LBP )
● Cost/Day:
1065792 ISK
( 687,435,840.00 LBP )
●
Cost/Month:
1065792 ISK
( 687,435,840.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
85264,46 CZK
( 325,623,216.00 LBP )
● Cost/Day:
170528,92 CZK
( 651,246,432.00 LBP )
●
Cost/Month:
170528,92 CZK
( 651,246,432.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
85264,46 CZK
( 325,623,216.00 LBP )
● Cost/Day:
170528,92 CZK
( 651,246,432.00 LBP )
●
Cost/Month:
170528,92 CZK
( 651,246,432.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
85264,46 CZK
( 325,623,216.00 LBP )
● Cost/Day:
170528,92 CZK
( 651,246,432.00 LBP )
●
Cost/Month:
170528,92 CZK
( 651,246,432.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
85264,46 CZK
( 325,623,216.00 LBP )
● Cost/Day:
170528,92 CZK
( 651,246,432.00 LBP )
●
Cost/Month:
170528,92 CZK
( 651,246,432.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
85264,46 CZK
( 325,623,216.00 LBP )
● Cost/Day:
170528,92 CZK
( 651,246,432.00 LBP )
●
Cost/Month:
170528,92 CZK
( 651,246,432.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
13202,15 SAR
( 312,095,280.00 LBP )
● Cost/Day:
26404,3 SAR
( 624,190,560.00 LBP )
●
Cost/Month:
26404,3 SAR
( 624,190,560.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
13202,15 SAR
( 312,095,280.00 LBP )
● Cost/Day:
26404,3 SAR
( 624,190,560.00 LBP )
●
Cost/Month:
26404,3 SAR
( 624,190,560.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
13202,15 SAR
( 312,095,280.00 LBP )
● Cost/Day:
26404,3 SAR
( 624,190,560.00 LBP )
●
Cost/Month:
26404,3 SAR
( 624,190,560.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
13202,15 SAR
( 312,095,280.00 LBP )
● Cost/Day:
26404,3 SAR
( 624,190,560.00 LBP )
●
Cost/Month:
26404,3 SAR
( 624,190,560.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
13202,15 SAR
( 312,095,280.00 LBP )
● Cost/Day:
26404,3 SAR
( 624,190,560.00 LBP )
●
Cost/Month:
26404,3 SAR
( 624,190,560.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
2626 GBP
( 298,442,274.00 LBP )
● Cost/Day:
5252 GBP
( 596,884,548.00 LBP )
●
Cost/Month:
5252 GBP
( 596,884,548.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
2626 GBP
( 298,442,274.00 LBP )
● Cost/Day:
5252 GBP
( 596,884,548.00 LBP )
●
Cost/Month:
5252 GBP
( 596,884,548.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
2626 GBP
( 298,442,274.00 LBP )
● Cost/Day:
5252 GBP
( 596,884,548.00 LBP )
●
Cost/Month:
5252 GBP
( 596,884,548.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
2626 GBP
( 298,442,274.00 LBP )
● Cost/Day:
5252 GBP
( 596,884,548.00 LBP )
●
Cost/Month:
5252 GBP
( 596,884,548.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
2626 GBP
( 298,442,274.00 LBP )
● Cost/Day:
5252 GBP
( 596,884,548.00 LBP )
●
Cost/Month:
5252 GBP
( 596,884,548.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
3062,98 EUR
( 296,634,312.00 LBP )
● Cost/Day:
6125,96 EUR
( 593,365,500.00 LBP )
●
Cost/Month:
6125,96 EUR
( 593,365,500.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
3062,98 EUR
( 296,634,312.00 LBP )
● Cost/Day:
6125,96 EUR
( 593,365,500.00 LBP )
●
Cost/Month:
6125,96 EUR
( 593,365,500.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
3062,98 EUR
( 296,634,312.00 LBP )
● Cost/Day:
6125,96 EUR
( 593,365,500.00 LBP )
●
Cost/Month:
6125,96 EUR
( 593,365,500.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
3062,98 EUR
( 296,634,312.00 LBP )
● Cost/Day:
6125,96 EUR
( 593,365,500.00 LBP )
●
Cost/Month:
6125,96 EUR
( 593,365,500.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
3062,98 EUR
( 296,634,312.00 LBP )
● Cost/Day:
6125,96 EUR
( 593,365,500.00 LBP )
●
Cost/Month:
6125,96 EUR
( 593,365,500.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
3040 EUR
( 294,503,040.00 LBP )
● Cost/Day:
6080 EUR
( 589,006,080.00 LBP )
●
Cost/Month:
6080 EUR
( 589,006,080.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
3040 EUR
( 294,503,040.00 LBP )
● Cost/Day:
6080 EUR
( 589,006,080.00 LBP )
●
Cost/Month:
6080 EUR
( 589,006,080.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
3040 EUR
( 294,503,040.00 LBP )
● Cost/Day:
6080 EUR
( 589,006,080.00 LBP )
●
Cost/Month:
6080 EUR
( 589,006,080.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
3040 EUR
( 294,503,040.00 LBP )
● Cost/Day:
6080 EUR
( 589,006,080.00 LBP )
●
Cost/Month:
6080 EUR
( 589,006,080.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
3040 EUR
( 294,503,040.00 LBP )
● Cost/Day:
6080 EUR
( 589,006,080.00 LBP )
●
Cost/Month:
6080 EUR
( 589,006,080.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
2662 EUR
( 257,883,912.00 LBP )
● Cost/Day:
5324 EUR
( 515,767,824.00 LBP )
●
Cost/Month:
5324 EUR
( 515,767,824.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
2662 EUR
( 257,883,912.00 LBP )
● Cost/Day:
5324 EUR
( 515,767,824.00 LBP )
●
Cost/Month:
5324 EUR
( 515,767,824.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
2662 EUR
( 257,883,912.00 LBP )
● Cost/Day:
5324 EUR
( 515,767,824.00 LBP )
●
Cost/Month:
5324 EUR
( 515,767,824.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
2662 EUR
( 257,883,912.00 LBP )
● Cost/Day:
5324 EUR
( 515,767,824.00 LBP )
●
Cost/Month:
5324 EUR
( 515,767,824.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
2662 EUR
( 257,883,912.00 LBP )
● Cost/Day:
5324 EUR
( 515,767,824.00 LBP )
●
Cost/Month:
5324 EUR
( 515,767,824.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
30097 NOK
( 243,906,088.00 LBP )
● Cost/Day:
60194 NOK
( 487,812,176.00 LBP )
●
Cost/Month:
60194 NOK
( 487,812,176.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
30097 NOK
( 243,906,088.00 LBP )
● Cost/Day:
60194 NOK
( 487,812,176.00 LBP )
●
Cost/Month:
60194 NOK
( 487,812,176.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
30097 NOK
( 243,906,088.00 LBP )
● Cost/Day:
60194 NOK
( 487,812,176.00 LBP )
●
Cost/Month:
60194 NOK
( 487,812,176.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
30097 NOK
( 243,906,088.00 LBP )
● Cost/Day:
60194 NOK
( 487,812,176.00 LBP )
●
Cost/Month:
60194 NOK
( 487,812,176.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
30097 NOK
( 243,906,088.00 LBP )
● Cost/Day:
60194 NOK
( 487,812,176.00 LBP )
●
Cost/Month:
60194 NOK
( 487,812,176.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
28482,76 SEK
( 239,476,656.00 LBP )
● Cost/Day:
56965,52 SEK
( 478,961,720.00 LBP )
●
Cost/Month:
56965,52 SEK
( 478,961,720.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
28482,76 SEK
( 239,476,656.00 LBP )
● Cost/Day:
56965,52 SEK
( 478,961,720.00 LBP )
●
Cost/Month:
56965,52 SEK
( 478,961,720.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
28482,76 SEK
( 239,476,656.00 LBP )
● Cost/Day:
56965,52 SEK
( 478,961,720.00 LBP )
●
Cost/Month:
56965,52 SEK
( 478,961,720.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
28482,76 SEK
( 239,476,656.00 LBP )
● Cost/Day:
56965,52 SEK
( 478,961,720.00 LBP )
●
Cost/Month:
56965,52 SEK
( 478,961,720.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
28482,76 SEK
( 239,476,656.00 LBP )
● Cost/Day:
56965,52 SEK
( 478,961,720.00 LBP )
●
Cost/Month:
56965,52 SEK
( 478,961,720.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
12895,82 TRY
( 34,558,600.00 LBP )
● Cost/Day:
25791,64 TRY
( 69,119,880.00 LBP )
●
Cost/Month:
25791,64 TRY
( 69,119,880.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
12895,82 TRY
( 34,558,600.00 LBP )
● Cost/Day:
25791,64 TRY
( 69,119,880.00 LBP )
●
Cost/Month:
25791,64 TRY
( 69,119,880.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
12895,82 TRY
( 34,558,600.00 LBP )
● Cost/Day:
25791,64 TRY
( 69,119,880.00 LBP )
●
Cost/Month:
25791,64 TRY
( 69,119,880.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
12895,82 TRY
( 34,558,600.00 LBP )
● Cost/Day:
25791,64 TRY
( 69,119,880.00 LBP )
●
Cost/Month:
25791,64 TRY
( 69,119,880.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
12895,82 TRY
( 34,558,600.00 LBP )
● Cost/Day:
25791,64 TRY
( 69,119,880.00 LBP )
●
Cost/Month:
25791,64 TRY
( 69,119,880.00 LBP )
Acquired haemophilia :
●
Cost/Unit:
4222855 LBP
( 4,222,855.00 LBP )
● Cost/Day:
8445710 LBP
( 8,445,710.00 LBP )
●
Cost/Month:
8445710 LBP
( 8,445,710.00 LBP )
Congenital FVII deficiency :
●
Cost/Unit:
4222855 LBP
( 4,222,855.00 LBP )
● Cost/Day:
8445710 LBP
( 8,445,710.00 LBP )
●
Cost/Month:
8445710 LBP
( 8,445,710.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
4222855 LBP
( 4,222,855.00 LBP )
● Cost/Day:
8445710 LBP
( 8,445,710.00 LBP )
●
Cost/Month:
8445710 LBP
( 8,445,710.00 LBP )
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
4222855 LBP
( 4,222,855.00 LBP )
● Cost/Day:
8445710 LBP
( 8,445,710.00 LBP )
●
Cost/Month:
8445710 LBP
( 8,445,710.00 LBP )
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
4222855 LBP
( 4,222,855.00 LBP )
● Cost/Day:
8445710 LBP
( 8,445,710.00 LBP )
●
Cost/Month:
8445710 LBP
( 8,445,710.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info
You have to register to view this info